Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism

Journal of Endocrinological Investigation

Volumn 32, Issue 11, 2009, Pages 934-938

  Lenzi, A ^a   Balercia, G ^b   Bellastella, A ^c   Colao, A ^d   Fabbri, A ^e   Foresta, C ^f   Galdiero, M ^d   Gandini, L ^a   Krausz, C ^g   Lombardi, G ^d   Lombardo, F ^a   Maggi, M ^g   Radicioni, A ^a   Selice, R ^f   Sinisi, A A ^c   Forti, G ^g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

Author keywords

FSH; Functional hypogonadotropic hypogonadism; Hypogonadotropic hypogonadism; Male infertility; Testosterone

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ANAMNESIS; CONGENITAL DISORDER; FOLLITROPIN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; GONADOTROPIN RELEASE; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS FUNCTION; INFECTION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NOTE; PHYSICAL EXAMINATION; SEMEN ANALYSIS; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL;

ADULT; CHILD; CHORIONIC GONADOTROPIN; FOLLICLE STIMULATING HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; PUBERTY;

EID: 77649208901     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6714     Document Type: Note

References (29)

1. Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patient-2002 update. Endocr Pract 8: 440-56.
2. Klibanski A, Beitins IZ, Badger T, Little R, McArthur JW. Reproductive function during fasting in men. J Clin Endocrinol Metab 1981, 53: 258-63.
3. Corona G, Mannucci E, Forti G, Maggi M. Hypogonadism, ED, metabolic sindrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl 2009, 32: 587-98.
4. Dandona P, Dhindsa S, Chaudhuri A, et al. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med 2008, 8: 816-28.
5. Trarbach EB, Silveira LG, Latronico AC. Gentic insights into human isolated gonadotropin deficiency. Pituitary 2007,10: 381-91.
6. Lofrano-Porto A, Barra GB, Giacomini LA, et al. Luteinizing hormone beta-mutation and hypogonadism in man and woman. N Eng J Med 2007, 357: 897-904.
7. Falardeau J, Chung WC, Beenken A, et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008, 118: 2822-31.
8. Behan LA, Agha A. Endocrine consequences of adult traumatic brain injury. Horm Res 2007, 68 (Suppl 5): 18-21.
9. Kelberman D, Dattani MT. Hypopituitarism oddities: congenital causes. Horm Res 2007, 68 (Suppl 5): 138-44.
10. World Health Organization Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge University Press Cambridge, 1999.
11. Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999, 84: 3673-80.
12. Isidori AM, Giannetta E, Lenzi A. Male hypogonadism. Pituitary 2008, 11: 171-80.
13. Yalti S, Gürbüz B, Fiçicioglu C. Serum levels of inhibin B in men and their relationship with gonadal hormones, testicular volume, testicular biopsy results and sperm parameters. J Obstet Gynaecol 2002, 22: 649-54.
14. Anawalt BD, Bebb RA, Matsumoto AM, et al. Serum inhibin B levels reflect sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996, 81: 3341-5.
15. Anderson RA, Sharpe RM. Regulation of inhibin production in the human male and its clinical applications. Int J Androl 2000, 23: 136-44.
16. Fujisawa M, Yamasaki T, Okada H, Kamidono S. The significance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod 2002, 17: 968-78.
17. Behre HM, Greb RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005, 15: 451-6.
18. Ahda Y, Gromoll J, Wunsch A, et al. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 2005, 26: 494-9.
19. Pengo M, Ferlin A, Arredi B, et al. FSH receptor gene polymorphisms in fertile and infertile Italian men. Reprod Biomed Online 2006, 13: 795-800.
20. Matsumoto AM. Hormonal therapy of male hypogonadism. Endocrinol Metab Clin North Am 1994, 23: 857-75.
21. Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howies CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 2009, 92: 594-604.
22. Sinisi AA, Esposito D, Maione L, et al. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod 2008, 23: 1029-34.
23. Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002, 17: 625-33.
24. Burris AS, Clark RV, Vantman DJ, Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril 1988, 50: 343-7.
25. Dohle GR, Jungwirth A, Kopa Z, et al. Guidelines on male infertility. European Association of Urology 2007 Update.
26. Kamischke A, Behre HM, Bergmann M, Simoni M, Schäfer T, Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998, 13: 596-603.
27. Foresta C, Selice R, Ferlin A, Garolla A. Recombinant FSH in the treatment of oligozoospermia. Expert Opin Biol Ther 2009, 9: 659-66.
28. Isidori AM, Pozza C, Gianfrilli D, Isidori A. Medical treatment to improve sperm quality. Reprod Biomed Online 2006, 12: 704-14.
29. Attia AM, Al-lnany HG, Proctor ML. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2006, 1: CD005071.